Kenya Patient Summary FHIR IG
0.1.0 - ci-build Kenya flag

Kenya Patient Summary FHIR IG - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

CodeSystem: KPS.D Treatment Data Elements

Official URL: https://shr.tiberbuapps.com/fhir/CodeSystem/kpsd-treatment-codes Version: 0.1.0
Active as of 2025-12-09 Computable Name: KPSDTreatmentCodes

CodeSystem representing treatment and medication-related data elements under the Kenya Patient Summary (KPS.D).

This Code system is referenced in the content logical definition of the following value sets:

  • This CodeSystem is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

This case-sensitive code system https://shr.tiberbuapps.com/fhir/CodeSystem/kpsd-treatment-codes defines the following codes:

CodeDisplayDefinition
KPS.D.DE.1 Medication Reason Clinical reason for prescribing or using the medication (linked to a health condition)
KPS.D.DE.2 Intended Use Purpose such as prevention, treatment, diagnostic, anaesthesia, or equipment care
KPS.D.DE.3 Medication Name/Code Medication administered or intended for administration
medicationStatus Medication Status Availability status of the medication
medicationStatusActive Active The medication is currently in use
medicationStatusInactive Inactive The medication is not currently in use
medicationStatusError Entered in Error The medication was recorded by mistake
medicationForm Medication Form Form of the medication (e.g., tablet, capsule, powder)
KPS.D.DE.3.4 Tablet Solid dose form intended for oral administration.
KPS.D.DE.3.5 Capsule Oral dosage form in a gelatin shell.
KPS.D.DE.3.6 Liquid Oral or injectable solution/suspension dosage form.
KPS.D.DE.3.7 Powder Dry substance that can be reconstituted or used directly.
KPS.D.DE.4 Active Ingredient List Substance(s) that produce therapeutic effect (e.g., paracetamol)
KPS.D.DE.4.1 Paracetamol Common analgesic and antipyretic agent.
KPS.D.DE.4.2 Amoxicillin Broad-spectrum beta-lactam antibiotic.
KPS.D.DE.4.3 Metronidazole Antibiotic and antiprotozoal medication.
KPS.D.DE.4.4 Ibuprofen NSAID used for pain relief, fever, and inflammation.
KPS.D.DE.4.5 Artemether + Lumefantrine Antimalarial combination therapy.
KPS.D.DE.5 Strength Dosage strength of active ingredient (e.g., 500mg/tablet)
KPS.D.DE.7 Dosage Regimen Dosing schedule: amount, frequency, duration (e.g., 1 tablet every 24h for 10 days)
KPS.D.DE.8 Route of Administration Pathway for administering the product (e.g., oral, intravenous)
KPS.D.DE.9 Date of Onset of Treatment Start date for prescribed medication use
KPS.D.DE.10 Plan of Care Narrative of therapeutic plans including diet, exercise, surgery, goals, and follow-ups
KPS.D.DE.11 External Reference Link to guidelines such as CPGs, emergency protocols, or other clinically relevant references
KPS.D.DE.12 Related With Indicates which Patient Summary entries this information relates to (e.g., link to a rare disease entry)